|
|
For efficient collection and recovery of DNA including crime scene trace and epithelial cells
Show details
|
|
|
|
For clinically reliable determination of the PITX2 methylation ratio in lymph node-positive, estrogen receptor-positive and HER2-negative high-risk breast cancer patient tissue samples
Show details
|
|
|
|
For sensitive detection of clinically proven somatic mutations in the EGFR oncogene, on cfDNA (circulating-free DNA) extracted from plasma samples
Show details
|
|
|
|
For sequencing-based detection and quantitation of cancer-related gene mutations in the NRAS gene
Show details
|
|
|
|
For IVD-validated mutation and methylation analysis using Pyrosequencing technology
Show details
|
|
|
|
For quantitative detection of Epstein-Barr virus DNA using real-time PCR
Show details
|
|
|
|
For purification of viral nucleic acids from human plasma and serum for in vitro diagnostic use
Show details
|
|
|
|
For preamplification of cDNA prior to real-time PCR miRNA analysis using the Fluidigm BioMark System
Show details
|
|
|
|
For real-time PCR profiling of miRNAs using the Fluidigm BioMark System
Show details
|
|
|
|
For targeted sequencing of established autosomal and Y-STR markers
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of Exonuclease I in custom formulations.
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of E. coli Pyrophosphatase in custom formulations.
Show details
|
|
|
|
Messophilic, highly processive, replicative DNA Polymerase
Show details
|
|
|
|
For effectively hydrolyzing inorganic pyrophosphate (PPi), helping maintain the enzymatic activity
Show details
|
|
|
|
For estimation of appearance and biogeographic ancestry with community-approved SNPs
Show details
|
|
|
|
For exceptionally high synthesis and replication fidelity rates due to highly processive DNA polymerase
Show details
|
|
|
|
For binding and stabilizing single-stranded DNA (ssDNA) during various DNA polymerase-mediated reactions
Show details
|
|
|
|
For fast, targeted whole genome library preparation of SARS-CoV-2 for genomic surveillance and variant detection
Show details
|
|
|
|
For removal of single-stranded primers in PCR reactions
Show details
|
|
|
|
For fully automated DNA/RNA purification from a broad range of samples with varying input volumes, with the QIAsymphony SP, and integrated assay set up with the QIAsymphony AS.
Show details
|
|
|
|
For quantification of BCR-ABL1 Mbcr, MMR, MR4, and MR4.5 results reporting on the International Scale (IS)
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of Terminal Deoxynucleotidyl Transferase (TdT) in custom formulations.
Show details
|
|
|
|
For quantitative measurements of methylation status in exon 1 of the human MGMT gene
Show details
|
|
|
|
For sequencing-based detection and quantitation of cancer-related gene mutations in the BRAF gene
Show details
|
|
|
|
For sequencing-based detection and quantitation of cancer-related gene mutations in the EGFR gene
Show details
|
|
|
|
For sequencing-based detection and quantitation of cancer-related gene mutations in the KRAS gene
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of T4 RNA Ligase 2 in custom formulations.
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of T4 RNA Ligase 1 in custom formulations.
Show details
|
|
|
|
For the selective lysis of erythrocytes from human blood and bone marrow aspirates
Show details
|
|
|
|
For collection of whole blood samples and stabilization of circulating cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction
Show details
|
|
|
|
For the ligation of single-stranded or double-stranded RNA molecules, as well as RNA-DNA hybrids
Show details
|
|
|
|
For the ligation of RNA molecules, facilitating the joining of RNA fragments or the addition of RNA adapters
Show details
|
|
|
|
For joining or ligation of DNA fragments, particularly in DNA sequencing and cloning techniques
Show details
|
|
|
|
For facilitating the labeling of DNA probes and tailing of DNA fragments
Show details
|
|
|
|
For dye-based one-step RT-PCR on the QIAcuity digital PCR instruments
Show details
|
|
|
|
For broad, sensitive and reliable CALR mutation detection to improve patient diagnosis
Show details
|
|
|
|
For in vitro transcription and synthesizing RNA from a DNA template
Show details
|
|
|
|
For the hands-free isolation of DNA from soil and stool using your automation workflow of choice
Show details
|
|
|
|
For multiplex amplification of all Chinese National database loci and CODIS-required markers with an innovative Quality Sensor
Show details
|
|
|
|
For efficient digestion of proteins in biological samples and for eliminating DNases and RNases during nucleic acid isolation
Show details
|
|
|
|
For qualitative detection of mutations in the KRAS oncogene using real-time PCR
Show details
|
|
|
|
For sensitive detection of the most frequently occurring somatic mutations in the EGFR oncogene in less than 4 hours
Show details
|
|
|
|
For qualitative detection of 11 mutations in the PIK3CA gene by real-time PCR
Show details
|
|
|
|
For quantitative detection of mutations in exons 3, and 4 of the human KRAS oncogene, and exons 2, 3, and 4 of the human NRAS oncogene
Show details
|
|
|
|
For the detection of 12 IDH1 and IDH2 mutations in glioma
Show details
|
|
|
|
For qualitative measurement of somatic mutations in the BRAF oncogene
Show details
|
|
|
|
NeuMoDx accessories, reagents and consumables are intended for in vitro diagnostic use. Product availability may vary from country to country. Contact your country representative for further details.
Show details
|
|
|
|
For sexual- and reproductive-health-related infectious disease using real-time PCR molecular testing
Show details
|
|
|
|
For triage testing of women who are high-risk HPV positive or have ASC-US cytology
Show details
|
|
|
|
NeuMoDx respiratory assays are intended for in vitro diagnostic use. Product availability may vary from country to country. Contact your country representative for further details.
Show details
|
|
|
|
Comprehensive oncology profiling combining gene fusion detection, gene expression analysis and single nucleotide variant (SNV) calling in just one assay
Show details
|
|
|
|
Comprehensive oncology profiling combining gene fusion detection, gene expression analysis and single nucleotide variant (SNV) calling in just one assay
Show details
|
|
|
|
For preparing libraries from unidentified persons and remains samples
Show details
|
|
|
|
The NeuMoDx system and assays are intended for in vitro diagnostic use. Product availability may vary from country to country. Contact your country representative for further details.
Show details
|
|
|
|
For rapid rRNA removal for RNA-seq library preparation from Caenorhabditis elegans (worm) samples
Show details
|
|
|
|
For rapid rRNA removal for RNA-seq library preparation from fish total RNA samples
Show details
|
|
|
|
For rapid rRNA removal for RNA-seq library preparation from Drosophila melanogaster (fly) samples
Show details
|
|
|
|
To support customers developing in-house assays using real-time PCR molecular testing
Show details
|
|
|
|
For detection and identification of 42 mutations in exons 18, 19, 20 and 21 of the EGFR gene
Show details
|
|
|
|
OEM by QIAGEN offers bulk manufacturing of ER/A-Tailing Enzyme Mix in custom formulations.
Show details
|
|
|
|
For automated purification of ccfDNA from 1-96 samples using the QIAsymphony SP
Show details
|
|
|
|
For detection of human papillomavirus infections using PCR technology
Show details
|
|
|
|
For protease digestion during DNA and RNA preparation
Show details
|
|
|
|
FAQ ID -2713
Show details
|
|
|
|
FAQ ID -2741
Show details
|
|
|
|
FAQ ID -2728
Show details
|
|
|
|
FAQ ID -2775
Show details
|
|
|
|
FAQ ID -2750
Show details
|
|
|
|
FAQ ID -2709
Show details
|
|
|
|
FAQ ID -2733
Show details
|
|
|
|
FAQ ID -2720
Show details
|
|
|
|
FAQ ID -2761
Show details
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID - 3271
Show details
|
|
|
|
FAQ ID — 3416
Show details
|
|
|
|
FAQ ID - 3481
Show details
|
|
|
|
FAQ ID — 3424
Show details
|
|
|
|
FAQ ID - 3486
Show details
|
|
|
|
FAQ ID - 3432
Show details
|
|
|
|
FAQ ID -2916
Show details
|
|
|
|
FAQ ID -2914
Show details
|
|
|
|
FAQ ID -2986
Show details
|
|
|
|
FAQ ID -2998
Show details
|
|
|
|
FAQ ID -2993
Show details
|
|
|
|
FAQ ID -2924
Show details
|
|
|
|
FAQ ID -3170
Show details
|
|
|
|
FAQ ID -2683
Show details
|
|
|
|
FAQ ID -2679
Show details
|
|
|
|
FAQ ID -2604
Show details
|
|
|
|
FAQ ID -2546
Show details
|
|
|
|
FAQ ID -2550
Show details
|
|
|
|
FAQ ID -2430
Show details
|
|
|
|
FAQ ID -2427
Show details
|
|
|
|
FAQ ID -2421
Show details
|
|
|
|
FAQ ID -3094
Show details
|
|
|
|
FAQ ID -3052
Show details
|
|
|
|
FAQ ID -3072
Show details
|
|
|
|
FAQ ID -1365
Show details
|
|
|
|
FAQ ID -1363
Show details
|
|
|
|
FAQ ID -1414
Show details
|
|
|
|
FAQ ID -2361
Show details
|
|
|
|
FAQ ID -2363
Show details
|
|
|
|
FAQ ID -2028
Show details
|
|
|
|
FAQ ID -2072
Show details
|
|
|
|
FAQ ID -2093
Show details
|
|
|
|
FAQ ID -2033
Show details
|
|
|
|
FAQ ID -2286
Show details
|
|
|
|
FAQ ID -2287
Show details
|
|
|
|
FAQ ID -2270
Show details
|
|
|
|
FAQ ID -2119
Show details
|
|
|
|
FAQ ID -1753
Show details
|
|
|
|
FAQ ID -1756
Show details
|
|
|
|
FAQ ID -1912
Show details
|
|
|
|
FAQ ID -1914
Show details
|
|
|
|
FAQ ID -1599
Show details
|
|
|
|
FAQ ID -1832
Show details
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID -1026
Show details
|
|
|
|
|
|
|
|
FAQ ID -1287
Show details
|
|
|
|
FAQ ID -1219
Show details
|
|
|
|
FAQ ID - 3632
Show details
|
|
|
|
FAQ ID - 3635
Show details
|
|
|
|
FAQ ID -1121
Show details
|
|
|
|
FAQ ID -1127
Show details
|
|
|
|
FAQ ID -1120
Show details
|
|
|
|
FAQ ID -1140
Show details
|
|
|
|
FAQ ID -1180
Show details
|
|
|
|
FAQ ID -1105
Show details
|
|
|
|
FAQ ID -2883
Show details
|
|
|
|
FAQ ID - 3713
Show details
|
|
|
|
FAQ ID - 141485
Show details
|
|
|
|
FAQ ID - 141491
Show details
|
|
|
|
FAQ ID - 141500
Show details
|
|
|
|
FAQ ID - 141502
Show details
|
|
|
|
FAQ ID - 141516
Show details
|
|
|
|
FAQ ID - 143076
Show details
|
|
|
|
FAQ ID CON0028
Show details
|
|
|
|
FAQ ID CON0043
Show details
|
|
|
|
FAQ ID POD0034
Show details
|
|
|
|
FAQ ID POD0025
Show details
|
|
|
|
FAQ ID CON0044
Show details
|
|
|
|
FAQ ID -9115
Show details
|
|
|
|
FAQ ID -9126
Show details
|
|
|
|
FAQ ID -9069
Show details
|
|
|
|
FAQ ID -90990
Show details
|
|
|
|
FAQ ID -9097
Show details
|
|
|
|
FAQ ID -9026
Show details
|
|
|
|
FAQ ID -9028
Show details
|
|
|
|
FAQ ID -9027
Show details
|
|
|
|
FAQ ID -9032
Show details
|
|
|
|
|
|
|
|
|
|
|
|
In this webinar, we will take a look at a large-scale SNP-based forensic identification panel for DNA analysis with massively parallel sequencing (MPS). The panel was specifically designed for the challenges of identifying missing persons; where DNA is frequently highly degraded, and relationship tests may involve reference samples from across several generations and in a deficient pedigree.
Show details
|
|
|
|
The FBI CODIS Core Loci Working Group have published the recommendation that the CODIS core loci should be expanded, and a combination of STR markers from the Combined DNA Index System (CODIS), the European Network of Forensic Science Institutes (ENFSI), and the European DNA Profiling Group (EDNAP) should be used to improve the accuaracy of forensic testing.
QIAGEN has developed new kits — Investigator 24plex Kits — that coamplify all 23 recommended markers. The kits use novel 6-dye technology to keep the amplicon length of markers short while avoiding overlapping of markers. Kits are available for purified DNA from casework and for reference samples.
This webinar will outline the benefits of the Investigator 24plex Kits and highlight the improved workflow, which saves unnecessary re-runs of a sample by use of an internal “Quality Sensor” control.
This unique Quality Sensor can distinguish:
Successful amplification
Degraded DNA
Inhibited DNA
No DNA
Failed PCR amplification
Join us to learn how to improve results and streamline your forensic STR analysis with the new Investigator 24plex Kits.
Show details
|
|
|
|
The core short tandem repeats (STRs) in worldwide use have served the forensic analyst very well for many years. Further, recent expansions of European Standard STR sets plus ongoing discussions to extend CODIS have brought powerful upgrades to the battery of core markers available. However, there are still scenarios when supplementary STRs could enhance the data necessary for interpreting complex forensic patterns: making safer inferences about relatedness across distant relationships in deficient pedigrees, and in the not too distant future, improving the specificity of familial searching or expanding the points of reference to better interpret mixed profiles.
The QIAGEN HDplex Kit contains 9 completely novel STRs in addition to ESS or CODIS D12S39, D18S51 and SE33 markers. On an average, these 9 novel STRs provide higher powers of discrimination than kits using the core loci alone.
This webinar will outline the completed studies on worldwide patterns of variability in the 12 novel HDplex STRs and their ability to enhance the power of paternity analyses when combined with existing markers.
It will also describe the upgraded pop.STR allele frequency browser which provides data for 23 core STRs plus a total of 28 supplementary STRs in 56 global populations.
Join us to learn more on:
Enhancing data necessary for interpreting complex forensic patterns with supplementary STRs
Making safer inferences about relatedness across distant relationships in deficient pedigrees
Improving the specificity of familial searching to better interpret mixed profiles
Show details
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID -1023
Show details
|
|
|
|
FAQ ID -1137
Show details
|
|
|
|
FAQ ID -1398
Show details
|
|
|
|
FAQ ID -1501
Show details
|
|
|
|
FAQ ID -1506
Show details
|
|
|
|
FAQ ID -1512
Show details
|
|
|
|
FAQ ID -2668
Show details
|
|
|
|
FAQ ID -2673
Show details
|
|
|
|
FAQ ID -2681
Show details
|
|
|
|
FAQ ID -2690
Show details
|
|
|
|
FAQ ID -2749
Show details
|
|
|
|
|
|
|
|
FAQ ID -3178
Show details
|
|
|
|
FAQ ID - 3431
Show details
|
|
|
|
FAQ ID - 3698
Show details
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID - 9211
Show details
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID - 9205
Show details
|
|
|
|
|
|
|
|
FAQ ID - 3372
Show details
|
|
|
|
FAQ ID - 3388
Show details
|
|
|
|
|
|
|
|
|
|
|
|
FAQ ID -1565
Show details
|
|
|
|
FAQ ID -1422
Show details
|
|
|
|
FAQ ID -1155
Show details
|
|
|
|
FAQ ID -1419
Show details
|
|
|
|
FAQ ID -1410
Show details
|
|
|
|
FAQ ID -1423
Show details
|
|
|
|
FAQ ID -1402
Show details
|
|
|
|
FAQ ID - 3960
Show details
|
|
|
|
FAQ ID - 3963
Show details
|
|
|
|
FAQ ID -2719
Show details
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|